跳至主要内容
临床试验/EUCTR2006-003752-38-IT
EUCTR2006-003752-38-IT进行中(未招募)不适用

A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - ND

OSPEDALE ONCOLOGICO DI BARI0 个研究点开始时间: 2007年6月14日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. Histologically or cytologically proven advanced breast carcinoma
  • 2. Patients pretreated with taxanes plus/minus anthracyclines
  • 3. Age >18 and < 75 years
  • 4. Life expectancy > 3 months
  • 5. Normal cardiac function
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. History of prior malignancy in the last 10 years
  • 2. Symptomatic peripheral neuropathy
  • 3. Other serious illness or medical condition
  • 4. Concurrent treatment with other experimental drugs
  • 5. ASAT (SGOT) and/or ALAT (SGPT) > 1.5 x UNL associated with alkaline phosphatase > 2.5 x UNL

研究者

发起方
OSPEDALE ONCOLOGICO DI BARI

相似试验

A phase II study of Capecitabine in combination with... | 临床试验